Latest Conference Articles

In this podcast, Maisam Fazel, FRCS, MS, MB BChir, discusses his research into a checklist for breast cancer surgeons.

Dr. Daniel Osman, director of the Miami Breast Cancer Conference, on Designing the Program for the MBCC

Maisam Fazel, FRCS, MS, MB BChir, of Imperial College Healthcare NHS Trust in the United Kingdom on Trends in Surgical Training

As the number of breast cancer survivors grows, so does the emphasis on establishing individualized survivorship plans

Preoperative neoadjuvant systemic therapy can be valuable for patients even if they do not achieve a pathologic complete response

With thousands of clinical trials in play, many oncology specialists are reluctant to embrace findings from newly-released studies

Should genomic profiles be used routinely to determine which breast cancer patients receive adjuvant chemotherapy

Personalized treatment in oncology is a popular concept these days, but the goal remains elusive

It is time to rethink the way oncologists in the United States are treating ductal carcinoma in situ

The addition of sorafenib to capecitabine as a first-line therapy for patients with advanced breast cancer

Daniel A. Osman, MD, Founder and Course Director of the Miami Breast Cancer Conference Discusses Methods for Detecting Malignant Conditions in Breast Cancer

The climate for medical malpractice litigation in breast cancer treatment seems to be worsening

Breast pain is among the most common reasons that women seek medical attention from a breast specialist.